Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 142 participants.

Also called NCT07754318

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 142 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07754318
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07754318. Allocation not applicable; no masking; primary purpose treatment. Start 2026-08-26 (actual); primary completion 2028-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)
Acronym
ATHENA
Condition
AAA - Abdominal Aortic Aneurysm
Intervention (Device)
Heli-FX EndoAnchor System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct07754318
Content hash
a41dc34cefa602ed4db342a7ec4402bb6ae201975fcd7d7baf07889942ae72da